Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering
August 11, 2023 13:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
August 08, 2023 22:30 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023
July 25, 2023 13:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
June 26, 2023 08:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update
May 15, 2023 08:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma to Present at the OPMD International Conference
May 08, 2023 08:05 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma to Present at the JMP Securities Life Sciences Conference
May 08, 2023 08:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update
February 13, 2023 08:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program
January 23, 2023 09:48 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company developing...
Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational Update
November 10, 2022 08:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company developing...